GlassScriptPhysician profile
Barry M Uhl
NPI 1811936693
$8,647.89
in general payments reported to CMS, 2019-2025
76 companies · $2,546 in 2025
The $2,546 reported for 2025 was more than what 91% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $11.97 · 2021: $194 · 2022: $898 · 2023: $2,154 · 2024: $2,381 · 2025: $2,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,080.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $852.16 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $623.02 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $459.64 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Astrazeneca Pharmaceuticals LP | $338.46 | 2022-2025 | Imfinzi |
| Eisai INC. | $334.85 | 2022-2025 | |
| Janssen Biotech, INC. | $314.36 | 2022-2025 | Darzalex, Tecvayli, Erleada |
| Takeda Pharmaceuticals U.S.A., INC. | $300.44 | 2023-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Regeneron Healthcare Solutions, INC. | $274.66 | 2022-2025 | Libtayo, Lynozyfic |
| Genzyme Corporation | $269.88 | 2019-2025 | |
| Genentech USA, INC. | $246.59 | 2023-2025 | Venclexta, Tecentriq, Hemlibra |
| Astellas Pharma US INC | $236.96 | 2019-2025 | Xtandi, Padcev |
| Pfizer INC. | $194.97 | 2022-2024 | |
| Daiichi Sankyo INC. | $194.31 | 2019-2025 | Enhertu, Vanflyta, Injectafer |
| Sirtex Medical INC | $188.93 | 2019 | |
| Rigel Pharmaceuticals, INC. | $170.84 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.66 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.35 | 2019-2025 | |
| Puma Biotechnology, INC. | $148.00 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $146.56 | 2021-2023 | Imbruvica |
| Pharmaessentia USA Corporation | $136.86 | 2024-2025 | Besremi |
| Lilly USA, LLC | $135.35 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Beigene USA, INC. | $131.34 | 2023-2025 | Brukinsa |
| Karyopharm Therapeutics INC. | $125.64 | 2024-2025 | Xpovio |
| Tersera Therapeutics LLC | $117.89 | 2023-2025 | Zoladex, Quzyttir |
| Genmab U.S., INC. | $113.30 | 2024-2025 | Epkinly |
| Alexion Pharmaceuticals, INC. | $111.72 | 2023-2024 | Ultomiris |
| Coherus Oncology, INC. | $105.32 | 2023-2025 | Loqtorzi |
| Sumitomo Pharma America, INC. | $101.45 | 2023-2025 | Orgovyx |
| Blueprint Medicines Corporation | $100.32 | 2022-2025 | Ayvakit |
| Deciphera Pharmaceuticals INC. | $89.23 | 2023-2025 | Qinlock, Tgct, Romvimza |
| Sobi, INC | $88.86 | 2023-2025 | |
| Seagen INC. | $80.06 | 2022-2023 | Adcetris, Tukysa |
| Stemline Therapeutics INC. | $68.25 | 2023-2025 | Orserdu |
| Taiho Oncology, INC. | $66.81 | 2024-2025 | |
| Amgen INC. | $66.16 | 2021-2023 | Xgeva, Vectibix, Nplate |
| Emd Serono, INC. | $63.20 | 2023-2025 | Bavencio |
| Siemens Medical Solutions USA, INC. | $60.96 | 2023-2025 | Truebeam, Bravos Afterloader System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.57 | 2024-2025 | Gilotrif |
| Alnylam Pharmaceuticals INC. | $53.77 | 2022-2025 | Givlaari, Amvuttra |
| Tempus Ai, INC | $53.27 | 2024-2025 | Xt Cdx |
| Springworks Therapeutics, INC. | $53.14 | 2024-2025 | Ogsiveo |
| Accord Healthcare, INC. | $50.68 | 2025 | |
| Exelixis INC. | $49.64 | 2019-2024 | Cabometyx |
| Pharmacosmos Therapeutics INC. | $48.56 | 2023-2025 | Monoferric |
| Novo Nordisk INC | $46.94 | 2024 | |
| Elekta, INC. | $46.36 | 2022 | |
| Recordati_rare_diseases_inc. | $46.10 | 2023-2024 | Sylvant |
| Celgene Corporation | $45.36 | 2019 | |
| Servier Pharmaceuticals LLC | $44.04 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $43.03 | 2024 | |
| Legend Biotech USA INC. | $41.38 | 2025 | Carvykti |
| Iovance Biotherapeutics, INC. | $38.16 | 2025 | Amtagvi |
| Morphosys, US INC. | $37.67 | 2022-2023 | Monjuvi |
| Aveo Pharmaceuticals, INC. | $33.81 | 2023-2024 | Fotivda |
| Dendreon Pharmaceuticals LLC | $33.79 | 2024 | Provenge |
| Ge Healthcare | $30.80 | 2025 | |
| Beone Medicines USA, INC. | $27.63 | 2025 | Brukinsa |
| Adaptive Biotechnologies Corporation | $26.08 | 2023 | Clonoseq |
| Octapharma USA, INC. | $24.89 | 2023 | Panzyga |
| Eusa Pharma (US) LLC | $24.30 | 2022 | |
| Immunogen, INC. | $23.94 | 2023 | Elahere |
| E.R. Squibb & Sons, L.L.C. | $23.01 | 2022 | |
| Mirati Therapeutics, INC. | $22.42 | 2024 | Krazati |
| Myovant Sciences INC. | $22.14 | 2021 | |
| Geron Corporation | $21.97 | 2025 | Rytelo |
| Novocure INC. | $21.64 | 2021 | |
| Accuray Incorporated | $21.07 | 2019 | |
| Dova Pharmaceuticals | $20.83 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.43 | 2021 | |
| Glaxosmithkline, LLC. | $19.38 | 2025 | Ojjaara |
| Tolmar, INC. | $18.54 | 2023 | |
| Sun Pharmaceutical Industries INC. | $18.09 | 2024 | |
| Heron Therapeutics, INC. | $13.63 | 2023 | Sustol |
| Global Blood Therapeutics, INC. | $13.48 | 2022 | |
| Kyowa Kirin, INC. | $11.10 | 2019 | |
| Emmaus Medical, INC. | $8.89 | 2023 | Endari |
Drugs and devices associated with these payments
Keytruda $519Lenvima $273Jakafi $250Kisqali $235Libtayo $196Brukinsa $159Monjuvi $158Ninlaro $150Elahere $144Besremi $137Welireg $135Verzenio $135Scemblix $133Xtandi $127Ayvakit $126Xpovio $126Fabhalta $126Jaypirca $120Darzalex $119Orgovyx $118Sarclisa $117Rezlidhia $116Tavalisse $116Tecvayli $114Epkinly $113Ultomiris $112Venclexta $107Padcev $102Enhertu $98.22Imbruvica $96.93Qinlock $89.23Doptelet $88.86Erleada $87.61Ibrance $85.94Talvey $85.25Vitrakvi $84.09Lynparza $82.53Fruzaqla $82.03Udenyca $79.47Nubeqa $73.84Orserdu $68.25Stivarga $67.45Lonsurf $66.81Inqovi $66.81Loqtorzi $60.91Zoladex $60.44Quzyttir $57.45Imfinzi $56.11Ogsiveo $53.14Alunbrig $53.06Camcevi $50.68Monoferric $48.56Retevmo $46.94Tecentriq $46.73Rybrevant $46.12Sylvant $46.10Tibsovo $44.04Truebeam $43.87Pylarify $43.03Vanflyta $42.85Tukysa $42.68Carvykti $41.38Pluvicto $39.13Mekinist $39.01Amtagvi $38.16Piqray $36.11Adcetris $34.47Fotivda $33.81Provenge $33.79Tgct $32.20Hemlibra $28.59Romvimza $28.32Xt Cdx $27.60Polivy $27.51Cabometyx $26.61Clonoseq $26.08Phesgo $25.41Perjeta $25.41Kadcyla $25.41Gilotrif $25.04Itovebi $24.91Panzyga $24.89Givlaari $24.44Lynozyfic $24.05Gavreto $23.71Jevtana $22.91Krazati $22.42Comirnaty $22.40Columvi $22.38Rytelo $21.97Tivdak $20.69Keytruda Qlex $20.63Zynyz $20.14Promacta $19.66Ojjaara $19.38Nerlynx $19.17Lutathera $18.68Eligard $18.54Odomzo $18.09Yonsa $18.09
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Uhl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.